Genmab A (GMAB) Short-term Investments (2020 - 2025)

Genmab A's Short-term Investments history runs 4 years deep, the most recent figure standing at $140.0 million for Q3 2025.

• Quarterly Short-term Investments rose 225.58% year-over-year to $140.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $140.0 million (up 225.58% YoY) and the FY2025 annual result came in at $80.0 million, down 38.46% from the prior year.
• Short-term Investments was $140.0 million for Q3 2025 at Genmab A, up from $122.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $200.0 million in Q4 2023 and bottomed at $2.0 million in Q2 2024.
• A 3-year average of $91.0 million and a median of $101.0 million in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments plunged 94.5% — and 2025, when it surged 6000.0%.
• Genmab A's Short-term Investments stood at $200.0 million in 2023, then plunged by 94.5% to $11.0 million in 2024, then soared by 1172.73% to $140.0 million in 2025.
• Business Quant data shows GMAB's Short-term Investments at $140.0 million in Q3 2025, $122.0 million in Q2 2025, and $80.0 million in Q1 2025.